These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23290834)

  • 1. Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009.
    Hirth JM; Tan A; Wilkinson GS; Berenson AB
    Vaccine; 2013 Feb; 31(8):1138-40. PubMed ID: 23290834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid.
    Inguva S; Barnard M; Ward LM; Yang Y; Pittman E; Banahan BF; Kirby TR; Noble SL
    Vaccine; 2020 Feb; 38(8):2051-2057. PubMed ID: 31980196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009.
    Hirth JM; Tan A; Wilkinson GS; Berenson AB
    Cancer; 2012 Nov; 118(22):5623-9. PubMed ID: 22544681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Papillomavirus Vaccine: Continuation, Completion, and Missed Opportunities.
    Richards MJ; Peters M; Sheeder J
    J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):117-21. PubMed ID: 26300233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HPV vaccine: are dosing recommendations being followed?
    Tan W; Viera AJ; Rowe-West B; Grimshaw A; Quinn B; Walter EB
    Vaccine; 2011 Mar; 29(14):2548-54. PubMed ID: 21300098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worsening disparities in HPV vaccine utilization among 19-26 year old women.
    Dempsey A; Cohn L; Dalton V; Ruffin M
    Vaccine; 2011 Jan; 29(3):528-34. PubMed ID: 21050904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital.
    Schluterman NH; Terplan M; Lydecker AD; Tracy JK
    Vaccine; 2011 May; 29(21):3767-72. PubMed ID: 21440038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US.
    Liu G; Kong L; Du P
    Papillomavirus Res; 2016 Dec; 2():1-8. PubMed ID: 26623444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of Human Papillomavirus Vaccine Completion Among Adolescent Girl Initiators.
    Rahman M; Laz TH; McGrath CJ; Berenson AB
    Clin Pediatr (Phila); 2015 Dec; 54(14):1328-33. PubMed ID: 25848128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.
    Adjei Boakye E; Lew D; Muthukrishnan M; Tobo BB; Rohde RL; Varvares MA; Osazuwa-Peters N
    Hum Vaccin Immunother; 2018; 14(8):2016-2024. PubMed ID: 29708826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing university students' sexual risk behaviors as predictors of human papillomavirus (HPV) vaccine uptake behavior.
    Rohde RL; Adjei Boakye E; Christopher KM; Geneus CJ; Walker RJ; Varvares MA; Osazuwa-Peters N
    Vaccine; 2018 Jun; 36(25):3629-3634. PubMed ID: 29753605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of human papillomavirus vaccine series completion among young adult female initiators.
    Rahman M; Laz TH; McGrath C; Berenson AB
    Hum Vaccin Immunother; 2014; 10(8):2163-7. PubMed ID: 25424919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider Payments And The Receipt Of Human Papillomavirus Vaccine Among Privately Insured Adolescents.
    Tsai Y; Lindley MC; Zhou F; Stokley S
    Health Aff (Millwood); 2018 Oct; 37(10):1587-1595. PubMed ID: 30273036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in human papillomavirus vaccine completion among vaccine initiators.
    Chou B; Krill LS; Horton BB; Barat CE; Trimble CL
    Obstet Gynecol; 2011 Jul; 118(1):14-20. PubMed ID: 21691158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of deductible health plans on receipt of the human papillomavirus vaccine series.
    Roblin DW; Ritzwoller DP; Rees DI; Carroll NM; Chang A; Daley MF
    J Adolesc Health; 2014 Mar; 54(3):275-81. PubMed ID: 24560035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010.
    Laz TH; Rahman M; Berenson AB
    Vaccine; 2012 May; 30(24):3534-40. PubMed ID: 22480927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses.
    Widdice LE; Bernstein DI; Leonard AC; Marsolo KA; Kahn JA
    Pediatrics; 2011 Jan; 127(1):77-84. PubMed ID: 21149425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey.
    Tiro JA; Tsui J; Bauer HM; Yamada E; Kobrin S; Breen N
    J Womens Health (Larchmt); 2012 Jun; 21(6):656-65. PubMed ID: 22420920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age at initiation of the human papillomavirus vaccine on the association between race/ethnicity and completion of the vaccine series.
    Hirth J; Ostovar-Kermani T; Gutierrez JA; Thompson EL; Barnett TE; Zoorob R
    Vaccine; 2024 Apr; 42(11):2827-2836. PubMed ID: 38519345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Completion of the Human Papillomavirus Vaccination Series Among Adolescent Users and Nonusers of School-Based Health Centers.
    Munn MS; Kay M; Page LC; Duchin JS
    Public Health Rep; 2019; 134(5):559-566. PubMed ID: 31404508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.